Clinical Trial

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion

Recruiting

Record status

This record was last updated September 8, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-20.

Status change: Not Yet Recruiting → Recruiting 2025-09-01

Trial Details

NCT Number	NCT07143695
Lead Sponsor	Cairo University
Conditions	Critically Ill
Enrollment	200 participants
Start Date	2025-09-01
Primary Completion	2026-08-01 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-08